Anna Stagno Sabrina Vari Alessio Annovazzi Vincenzo Anelli Michelangelo Russillo Francesco Cognetti Virginia Ferraresi
10.3389/fonc.2021.645008
Front Oncol
2021 May 31;11:645008.
braf v600 mutation braf inhibitor mek inhibitor drug resistance metastatic melanoma rechallenge targeted therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/34136385/
Case Reports
PMC8202400
34136385
Case Report: Rechallenge With BRAF and MEK Inhibitors in Metastatic Melanoma: A Further Therapeutic Option in Salvage Setting?
2021